Sit Investment Associates Inc Incyte Corp Transaction History

Sit Investment Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.42 Million - $1.71 Million	-22,975 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$60.85 - $83.98 $1.69 Million - $2.34 Million	-27,850 Reduced 54.8%	22,975 $1.54 Million
Q1 2018 Apr 20, 2018	SELL	$83.06 - $100.98 $71,431 - $86,842	-860 Reduced 1.66%	50,825 $4.24 Million
Q4 2017 Jan 10, 2018	BUY	$93.56 - $116.6 $346,172 - $431,420	3,700 Added 7.71%	51,685 $4.9 Million
Q3 2017 Oct 18, 2017	BUY	$109.15 - $138.27 $5.24 Million - $6.63 Million	47,985	47,985 $5.6 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.